An Overview of the Regulatory Landscape Relevant to Tissue and Cell Based Therapies within the EU, considering both Adult and Embryonic Stem Cells
Julian Hitchcock, Lawford Davies Denoon, speaking at Stem Cells & Bioprocessing Europe 2012.
Tissue Based Diagnostics for Predicting Drug Response: Challenges and Opportunities
Hartmut Juhl, Indivumed GmbH and Inostics GmbH, speaking at European Lab Automation 2012
The Voice of the Stem Cell Community
Bernard Siegel, Genetics Policy Institute, speaking at Stem Cells 2012
Joint Talk - Deciphering the Cell with GE Healthcare Cell Technologies / The Importance of High Content Analysis for Stem Cell Culture, Differentiation and Media Development
Dr. Bergendahl, Miltenyi Biotec GmbH, speaking at European Laboratory Automation 2012.
Functional microRNA Profiling for Improved iPSC Reprogramming
Jan Fiedler, Medical School Hannover, speaking at Genomics Research Europe 2012
Biobanking: Economics and Impact
Chana Rabiner, National Cancer Institute, speaking at European Laboratory Automation 2012.
The Brüstle-Patent-Case – Legal Background and Impacts to European Stem Cell Research and International Cooperation
Timo Faltus, University of Leipzig, speaking at Stem Cells & Bioprocessing Europe 2012.
Drug Discovery Technology using Human iPS Cells
Dr. Chikafumi Yokoyama, ReproCELL Inc., speaking at Stem Cells 2012
How to Improve Interoperability of biobanks: European and International Initiatives
Kurt Zatloukal, Medical University of Graz, speaking at European Lab Automation 2012